Summary: L-lactic acid transport plays an important role in the regulation of L-lactic acid circulation into and out of muscle. To clarify the transport mechanism of L-lactic acid in skeletal muscle, L-lactic acid uptake was investigated using a L6 cell line. mRNAs of monocarboxylate transporter (MCT) 1, 2 and 4 were found to be expressed in L6 cells. The [
Introduction
L-lactic acid produced by the anaerobic glycolytic pathway in contraction of skeletal muscles can be metabolized in the muscle itself. L-lactic acid transport is thought to play an important role in the regulation of L-lactic acid circulation into and out of muscle. Two factors may regulate the utilization of L-lactic acid in muscle: transport across the sarcommal membrane and the metabolic need of the muscle. In mammalian cells, it has been clearly demonstrated that L-lactic acid transport via a facilitated system occurs across the cell membrane. [1] [2] [3] On the other hand, speciˆc H ＋ W monocarboxylate cotransport has been demonstrated in sarcolemmal vesicles from skeletal muscle cells. [4] [5] [6] [7] These studies showed that L-lactic acid was transported by a mechanism obeying Michaelis-Menten kinetics. MCT1 has been found in allˆber types in muscle tissue, but it is more abundant in muscles that have a high percentage of oxidative cells than in glycolytic muscles and thus has been suggested to play a major role in in‰ux of lactic acid for oxidation. 8, 9) The other major MCT isoform found in muscles, especially in white muscleˆbers, is MCT4, 10, 11) which is thought to play a primary role in the eOEux of L-lactic acid from muscleˆbers. A third isoform expressed in skeletal muscle is MCT2, which has a low Km for L-lactic acid (0.7 mM). 12, 13) The L6 cell line is an established cell line obtained from rat muscle. However, the characteristics of the MCT-mediated L-lactic acid transport system and the eŠects of monocarboxylic acids and monocarboxylate dugs on this transport system have not been elucidated.
To elucidate the transport mechanism of L-lactic acid in L6 cells seems to clarify the physiological role of the MCT in skeletal muscles. At present, there is some evidence that MCTs may play a role in the transport of some drugs such as valproic acid and statins, inducing adverse events including myopathy and rhabdmyolysis. [14] [15] [16] [17] Accordingly, in terms of drug delivery to skeletal muscles, to clarify a role of MCT is possibility of leading to minimize the side eŠects and helps to understand about pharmacokinetic properties of drugs that have monocarboxylate structures within the molecules.
The aim of this study was to characterize L-lactic acid transport using an L6 cell line as a model of in vitro skeletal muscle. It is important to obtain a better understanding of the transport mechanism of L-lactic acid in skeletal muscle. The eŠects of monocarboxylic acids and monocarboxylate drugs on the uptake and eOEux of [ 14 C] L-lactic acid in L6 cells were investigated.
Materials and Methods
Chemicals: [ 14 C] L-lactic acid sodium salt was purchased from Amersham Life Science (Buckinghamshire, UK). L-lactic acid sodium salt was purchased from ICN Biomedicals Inc., Aurora, OH. Fluvastatin and pravastatin were kindly donated from Novartis Pharma (Tokyo, Japan) and Sankyo (Tokyo, Japan), respectively. All other reagents were of the highest grade available and used without further puriˆcation.
Cell culture: L6 cells were kindly provided by Dr. K. Miyazaki. The cells were routinely maintained in plastic culture ‰asks (Corning Incorporated Corning). These stock cells were subcultivated before reaching con‰uence. The medium used for growth of L6 cells was Dulbecco's modiˆed Eagle's medium (Sigma) with 10z fetal bovine serum (ICN Biomedicals, Inc., Aurora, OH) and 1z penicillin-streptomycin. The monolayer cultures were grown in an atmosphere of 5z CO 2 at 379 C. The standard medium was changed every 2 days. When the L6 cells reached con‰uence, they were harvested with 0.25 mM trypsin and 0.2z EDTA (0.5¿1 min at 379 C), resuspended, and seeded into a new ‰ask.
For the uptake and eOEux studies, L6 cells were seeded at a cell density of 1×10 5 cells W mL on 24-well plastic plates (Coster, Corning Incorporated Corning). The cell monolayers were fed a fresh growth medium every 2 days and were then used at 7 to 8 days for the uptake and eOEux experiments.
RT-PCR analysis: Total RNA was prepared from L6 cells using an RNeasy mini Kit and an RNase-Free DNase Set (QIAGEN). Single-strand cDNA was made from 2 mg total RNA by reverse transcription (RT) using an Omniscript RT Kit. PCR was performed using Hot Star Taq PCR (QIAGEN) with MCT1-4 speciˆc primers through 40 cycles of 949 C for 30 s, 519 C 1 min, and 729 C for 1 min. The sequences of the speciˆc primers were as follows: the sense sequence was 5?-TGC AAC GAC CAG TGA AGT GT-3? and the antisense sequence was 5?-CTC ATT GGA GGA AGT CCT AA-3? for rat MCT1: the sense sequence was 5?-TGG AGT GTT GCC CAG TTC TT-3? and the antisense sequence was 5?-CAC ACA GCT GCT TAT CTG CA-3? for rat MCT2: the sense sequence was 5?-TCA AGG CTG TTG GAC ACT CT-3? and the antisense sequence was 5?-TAC CTG ACG GCT GGG GTA CT-3? for rat MCT3: the sense sequence was 5?-GGT TTC ATA ACA GGG CTC AA-3? and the antisense sequence was 5?-AAA ACG GGG AGG TGG TTC AT-3? for rat MCT4: the sense sequence was 5?-GCC AAA AGG GTC ATC ATC TC-3? and the antisense sequence was 5?-AAA GGT GGA GGA ATG GGA GT-3? for rat GAPDH. The PCR products were subjected to electrophoresis on a 1z agarose gel and then visualized by ethidium bromide staining.
Uptake study: After removal of the growth medium, cells were washed with HEPES (pH 7.4) buŠer (25 mM D-glucose, 137 mM NaCl, 5.37 mM KCl, 0.3 mM Na2HPO4, 0.44 mM KH2PO4, 4.17 mM NaHCO3, 1.26 mM CaCl2, 0.8 mM MgSO4 and 10 mM HEPES) and preincubated at 379 C for 10 min with 0.5 mL of HEPES (pH 7.4) buŠer. Uptake was initiated by applying 500 mL MES (pH 6.0) buŠer (25 mM D-glucose, 137 mM NaCl, 5.37 mM KCl, 0.3 mM Na2HPO4, 0.44 mM KH2PO4, 4.17 mM NaHCO3, 1.26 mM CaCl2, 0.8 mM MgSO4 and 10 mM MES) or HEPES (pH 7.4) buŠer containing [
14 C] L-lactic acid (0.2 mCi W mL). The uptake study was performed at 379 C due to physiological temperature. After a predetermined time period, uptake was terminated by suctioning oŠ the applied solution and immersing the plates in ice-cold HEPES (pH 7.4) buŠer. The cells were then solubilized in 0.5 mL of 1z SDS W 0.2 N NaOH. The remainder of the sample (500 mL) was mixed with 8 mL of scintillation cocktail (ASC II, Amersham) to measure the radioactivity in a liquid scintillation counter (Packard, 1600TR). Protein concentration was measured by the method of Lowry et al. 18) with bovine serum albumin as a standard.
EOEux study: EOEux study was performed as described previously. 19) Brie‰y, after removal of the growth medium, cells were preincubated at 379 C for 10 min with 0.5 mL of HEPES (pH 7.4) buŠer. After removal of the medium, cells were incubated with 0.5 mL of MES (pH 6.0) buŠer containing [
14 C] L-lactic acid (1 mM) for 10 min at 379 C. After incubation, cells were washed with an ice-cold HEPES (pH 7.4) buŠer and re-incubated in [ 14 C] L-lactic acid -free medium for a certain time at 379 C. To measure the amount of residual [ 14 C] L-lactic acid in the cells, the medium was aspirated and the cells were washed rapidly with an ice-cold HEPES (pH 7.4) buŠer. The cells were solubilized in 0.5 mL of 1z SDS W 0.2 N NaOH. The remaining part of the sample (500 mL) was mixed with 8 mL of scintillation cocktail (ASC II, Amersham) to measure the radioactivity in a liquid scintillation counter (Packard, 1600TR).
Data Analysis: For kinetic studies, the MichaelisMenten constant (Km) and maximum uptake rate (Vmax) of L-lactic acid were estimated from the following equation using a nonlinear least-squares regression analysis program:
where v, S and Kd are uptake rate of L-lactic acid at 10 s, concentration of L-lactic acid and non-saturable Unless otherwise indicated, all data represent the mean±S.D. of the mean.
An unpaired, two-tailed Student's t-test was used to determine the signiˆcance of diŠerences between two group means, and a value of Pº0.05 was considered signiˆcant.
Results

RT-PCR analysis of the MCT family in L6 cells:
In order to clarify the subtypes of MCT present in the L6 cells, RT-PCR experiments were performed to determine MCT1-4 in L6 cells using total RNA isolated from L6 cells and speciˆc primers of rat MCT1-4. The mRNAs of MCT1, 2 and 4 were found to be expressed in L6 cells. (Fig. 1) .
Time course of L-lactic acid (1 mM) uptake by L6 cells: The time-courses of [
14 C] L-lactic acid uptake into L6 cells at pH 6.0 and pH 7.4 are shown in Fig. 2 . The [
14 C] L-lactic acid uptake was linear for 60 s. Uptake of [
14 C] L-lactic acid at pH 6.0 was greater than that at pH 7.4 (Fig. 2) .
pH and temperature dependence of L-lactic acid (1 mM) uptake by L6 cells: The eŠect of extracellular pH on [
14 C] L-lactic acid uptake by L6 cells was examined over the pH range of 5.5 to 8.0. The uptake of [ 14 C] L-lactic acid markedly increased with a decrease in extracellular pH. The [ 14 C] L-lactic acid uptake at pH 5.5 and 6.0 at 379 C was 3.0-fold greater than that at 49 C. Uptake experiments were therefore performed at pH 6.0 to characterize the L-lactic acid transport mechanism because the uptake at pH 6.0 is greater than that at pH 7.4 and because pH 6.0 closer to the physiological pH than is pH 5.5 (Fig. 3) .
Concentration dependence of L-lactic acid uptake by L6 cells: Figure 4 shows the concentration-dependent uptake of [ 14 C] L-lactic acid by L6 cells. Analysis using an Eadie-Hofstee plot showed that intracellular [ 14 
C]
L-lactic acid uptake was a saturable process. Nonlinear least-squares regression analysis revealed that Km and Vmax were 3.7 mM and 4.4 nmol W mg protein W s, respectively (Fig. 4) .
Inhibitory eŠects of related compounds on the uptake L-lactic acid (1 mM) by L6 cells: The eŠects of monocarboxylic acid, MCT inhibitors and other organic anions on the [
14 C] L-lactic acid uptake by L6 cells are summarized in Table 1 . Pyruvic acid, acetic acid, propionic acid, butyric acid and benzoic acid inhibited (1 mM) 39.1±7.5 *** Diclofenac sodium (1 mM) 56.0±5.7 *** Salicylic acid (10 mM) 30.0±3.9 *** Valproic acid (10 mM) 34.4±4.4 *** Nicotinic acid (10 mM) 53.0±2.9 *** Fluvastatin sodium (0.5 mM) 52.6±9.8 ** Pravastatin sodium (10 mM) 52.7±4.4 ***
The [ 14 C] L-lactic acid uptake was measured at 379 C and pH 6.0 for 10 s in the presence of each inhibitor. Each value represents the mean± S.D. of 3-18 determinations. **Pº0.01, ***Pº0.001, signiˆcantly diŠerent from control.
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Masaki KOBAYASHI, et al. EŠects of several inhibitory conditions on eOEux of L-lactic acid from L6 cells: EOEux of L-lactic acid from L6 cells was inhibited when the eOEux medium was at acidic pH (pH 6.0). Moreover, the eOEux was signiˆcantly inhibited by a-cyano-4-hydroxycinnamate and phloretin and was also markedly inhibited by monocarboxylate drugs (HMG-CoA reductase inhibitors), particularly ‰uvastatin ( Table 3) . Discussion L6 cells are used as an in vitro skeletal muscle model. In the present study, it was found that L-lactic acid was taken up into L6 cells via an H ＋ -coupled transport system. This process took place in a pH-, temperatureand concentration-dependent manner (Figs. 2-4) . The corresponding K m and V max values are 3.7 mM and 4.4 nmol W mg protein W s, respectively. This Km value is identical to that reported in MCT1-transfected Xenopus oocyte. 21) mRNAs of MCT1, MCT2 and MCT4 were expressed in L6 cells (Fig. 1) . The H ＋ -coupled L-lactic acid uptake by L6 cells appears to be speciˆc for monocarboxylic acids. The uptake of L-lactic acid was inhibited by monocarboxylic acids, including NSAIDS, HMG-CoA reductase inhibitors, valproic acid and nicotinic acid (Tables 1 and 2 ), and that neither dicarboxylic acids nor amino acids had any eŠect on the uptake of L-lactic acid by L6 cells. It also showed that DIDS, an anion-exchange inhibitor, has little eŠect on the uptake of L-lactic acid.
Benzoic acid, a substrate of MCT1, had competitive inhibitory eŠect on the uptake of [
14 C] L-lactic acid with an apparent Ki value of 1.7 mM (Fig. 5) . Thisˆnding is evidence that MCT1 is responsible for L-lactic acid uptake by L6 cells.
On the other hand, eOEux of L-lactic acid from L6 cells was decreased when the eOEux medium was at acidic pH (pH 6.0). Moreover, the eOEux was inhibited by a-cyano-4-hydroxycinnamate and phloretin (typical MCT1, 2 and 4 inhibitors) and by monocarboxylate drugs ( Table 3) . These results suggest that MCT participates in the eOEux of L-lactic acid from L6 cells. However, benzoic acid (a MCT1 substrate) had no eŠect on the eOEux of L-lactic acid. Accordingly, MCT2 or MCT4 is responsible for L-lactic acid eOEux by L6 cells. It has been reported that mRNA of MCT2 was absent in rat skeletal muscle 22, 23) and MCT4 mediated lactate eOEux out of glycolitically active myocytes. 23) Thus the transporter responsible for the eOEux of L-lactic acid from L6 cells seems to be MCT4. Further investigations to determine the transporter that is involved in the eOEux of L-lactic acid are in progress.
We suggests that MCT1 facilitates the uptake of Llactic acid into L6 cells, whereas MCT4 assists with the extrusion of L-lactic acid out of L6 cells. The previous reports support the idea that MCT1 plays a major role in in‰ux of L-lactic acid and MCT4 plays a role in the eOEux of L-lactic acid. 23 ) Accordingly, L6 cell line is a good model for the evaluation of MCT function in the muscle. In conclusion, MCT1 is responsible for L-lactic acid uptake by L6 cells and L-lactic acid eOEux in L6 cells seems to be mediated by MCT4. Theseˆndings provide important information to obtain better understanding of the transport mechanism of L-lactic acid in skeletal muscle and drug delivery to the skeletal muscle.
